DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactStocks

20 Stocks to watch today: HDFC Bank, ICICI life, Wipro, DLF, Ola Electric & Gland Pharma

BusinessLine 1 hr ago·15 Oct 2026, 3:26 pm

HDFC Bank, ICICI Life, Wipro, DLF, Ola Electric, Gland Pharma, Unimech, Solex Energy, Aurobindo Pharma, and others

Affected stocks

Neutral5 stocks

Gland Pharma

₹3,066.30

HDFCBANK

—

—

AUROPHARMA

—

SOLEX

—

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Gland Pharma (GLAND).
Category: Stocks.
Also mentions HDFCBANK, DLF, AUROPHARMA.

Why it matters

A routine update for Gland Pharma. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at BusinessLine.

More Stocks news

More news

Nifty bucks global AI selloff as heavyweights flex muscle

Mint · 58 min ago

Market selloff, rising rates test AI data centre deal boom

Economic Times · 1 hr ago

Wipro ADRs surge 5% to two-month high despite Q2 profit dip: Is anti-AI trade driving gains?

Wipro₹174.05▲ 0.00%

Mint · 1 hr ago

Index Outlook: At a critical juncture

BusinessLine · 1 hr ago

Pernod Ricard India sales grow 19% in Sept qtr; IPO plan awaits board approval

Economic Times · 1 hr ago

Why Bajaj Finance shares jump 3% amid ₹17,500-cr capital raise plans

Bajaj Finance₹965.25▲ 0.00%

BusinessLine · 1 hr ago

India-China trade jumps 29% to $91.76 billion, overtakes US in first half of FY27

Times of India · 1 hr ago

CCL Products Q2 results: Net profit jumps 29% to ₹130 crore as revenue rises 7.5%

CCL Products (I)₹1,085.40▲ 0.00%

CNBC-TV18 · 1 hr ago

The Vvaan – Force of the Forrest Box Office Day 21: Siddharth Malhotra Starrer Refuses To Fade Away In Week 3

NDTV Profit · 1 hr ago

Latest headlines

More news

Economy SEBI

Review of certain aspects of the Closing Auction Session, market timings and settlement methodology for derivatives contracts

SEBI · 45 min ago

India, Switzerland agree to expand trade ties; ink migration and mobility pact

BusinessLine · 51 min ago

Gadchiroli stands out for exemplary work in water conservation under PMDDKY scheme

BusinessLine · 54 min ago

SEBI CAS: Framework revised; auction window set, reference price calculation for eligible securities changed - Details

Mint · 55 min ago

Apollo Micro Systems

Apollo Micro Systems Limited — Analysts/Institutional Investor Meet/Con. Call Updates

Apollo Micro Systems₹417.10▲ 0.00%

NSE · 57 min ago

CAS review: Sebi announces last 30-minute VWAP method for settlement

Business Standard · 57 min ago

AstraZeneca strikes $40 million AI drug discovery deal with Insitro

Business Standard · 58 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.